Bellicum Pharmaceuticals, Inc.

BLCMNASDAQ Capital Market·USD·Closed

BLCMNASDAQ·USD·Closed

$0.07

−6.68%

$0.07

−$0.01 (6.68%)

52W Range

1thpctl

Volume

0.22×avg

Mkt Cap

778326USD

P/E

-0.1TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

1thpctl

Volume

0.22×avg

Market Cap

778326USD

P/E Ratio

-0.1TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-75.8% / yr

Operating margin-1798.7%

ROIC-134.6%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-586543.5×

Current ratio6.31×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required